The Sodium Pump Alpha1 Sub-unit: a Disease Progression-related Target for Metastatic Melanoma Treatment

Overview

Journal J Cell Mol Med

Specialties Cell Biology
Molecular Biology

Date 2009 Feb 27

PMID 19243476

Citations 54

Authors

Veronique Mathieu

Christine Pirker

Elisabeth Martin de Lassalle

Mathieu Vernier

Tatjana Mijatovic

Nancy DeNeve

Jean-Francois Gaussin

Mischael Dehoux

Florence Lefranc

Walter Berger

Robert Kiss

Affiliations

Soon will be listed here.

Abstract

Melanomas remain associated with dismal prognosis because they are naturally resistant to apoptosis and they markedly metastasize. Up-regulated expression of sodium pump alpha sub-units has previously been demonstrated when comparing metastatic to non-metastatic melanomas. Our previous data revealed that impairing sodium pump alpha1 activity by means of selective ligands, that are cardiotonic steroids, markedly impairs cell migration and kills apoptosis-resistant cancer cells. The objective of this study was to determine the expression levels of sodium pump alpha sub-units in melanoma clinical samples and cell lines and also to characterize the role of alpha1 sub-units in melanoma cell biology. Quantitative RT-PCR, Western blotting and immunohistochemistry were used to determine the expression levels of sodium pump alpha sub-units. In vitro cytotoxicity of various cardenolides and of an anti-alpha1 siRNA was evaluated by means of MTT assay, quantitative videomicroscopy and through apoptosis assays. The in vivo activity of a novel cardenolide UNBS1450 was evaluated in a melanoma brain metastasis model. Our data show that all investigated human melanoma cell lines expressed high levels of the alpha1 sub-unit, and 33% of human melanomas displayed significant alpha1 sub-unit expression in correlation with the Breslow index. Furthermore, cardenolides (notably UNBS1450; currently in Phase I clinical trials) displayed marked anti-tumour effects against melanomas in vitro. This activity was closely paralleled by decreases in cMyc expression and by increases in apoptotic features. UNBS1450 also displayed marked anti-tumour activity in the aggressive human metastatic brain melanoma model in vivo. The alpha1 sodium pump sub-unit could represent a potential novel target for combating melanoma.

Citing Articles

Simplified Method for Kinetic and Thermodynamic Screening of Cardiotonic Steroids through the K-Dependent Phosphatase Activity of Na/K-ATPase with Chromogenic pNPP Substrate.

Azalim-Neto P, Noel F, Silva S, Villar J, Barbosa L, ODoherty G Mol Pharmacol. 2024; 106(5):225-239.

PMID: 39187390 PMC: 11493336. DOI: 10.1124/molpharm.124.000934.

Sphaeropsidin A C15-C16 Cross-Metathesis Analogues with Potent Anticancer Activity.

Wagh S, Berthold D, Majeed I, Lewis L, Schilter D, Mertens B ChemMedChem. 2024; 19(18):e202400288.

PMID: 38895989 PMC: 11645891. DOI: 10.1002/cmdc.202400288.

Na,K-ATPase activity promotes macropinocytosis in colon cancer via Wnt signaling.

Tejeda-Munoz N, Azbazdar Y, Sosa E, Monka J, Wei P, Binder G Biol Open. 2024; 13(5).

PMID: 38713004 PMC: 11139033. DOI: 10.1242/bio.060269.

ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy.

Soumoy L, Genbauffe A, Mouchart L, Sperone A, Trelcat A, Mukeba-Harchies L Cancer Cell Int. 2024; 24(1):8.

PMID: 38178183 PMC: 10765859. DOI: 10.1186/s12935-023-03196-y.

Functional Analysis and Clinical Importance of ATP1A1 in Colon Cancer.

Sumiyoshi S, Shiozaki A, Kosuga T, Simizu H, Kudo M, Kiuchi J Ann Surg Oncol. 2023; 30(11):6898-6910.

PMID: 37407874 DOI: 10.1245/s10434-023-13779-8.

References

Jaeger J, Koczan D, Thiesen H, Ibrahim S, Gross G, Spang R . Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues. Clin Cancer Res. 2007; 13(3):806-15. DOI: 10.1158/1078-0432.CCR-06-1820. View

Cappellen D, Schlange T, Bauer M, Maurer F, Hynes N . Novel c-MYC target genes mediate differential effects on cell proliferation and migration. EMBO Rep. 2006; 8(1):70-6. PMC: 1796762. DOI: 10.1038/sj.embor.7400849. View

Zupi G, Scarsella M, Semple S, Mottolese M, Natali P, Leonetti C . Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence. Clin Cancer Res. 2005; 11(5):1990-8. DOI: 10.1158/1078-0432.CCR-04-1284. View

Molitoris B, Geerdes A, McIntosh J . Dissociation and redistribution of Na+,K(+)-ATPase from its surface membrane actin cytoskeletal complex during cellular ATP depletion. J Clin Invest. 1991; 88(2):462-9. PMC: 295361. DOI: 10.1172/JCI115326. View

Griffioen M, van Elsas A, Schrier P, Pustelnik T, Eichler H, Wolff K . Influence of increased c-Myc expression on the growth characteristics of human melanoma. J Invest Dermatol. 1999; 112(3):332-6. DOI: 10.1046/j.1523-1747.1999.00506.x. View

Barwe S, Anilkumar G, Moon S, Zheng Y, Whitelegge J, Rajasekaran S . Novel role for Na,K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility. Mol Biol Cell. 2004; 16(3):1082-94. PMC: 551475. DOI: 10.1091/mbc.e04-05-0427. View

Mijatovic T, Mathieu V, Gaussin J, De Neve N, Ribaucour F, Van Quaquebeke E . Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers. Neoplasia. 2006; 8(5):402-12. PMC: 1592454. DOI: 10.1593/neo.05850. View

Berger W, Hauptmann E, Elbling L, Vetterlein M, Kokoschka E, Micksche M . Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells. Int J Cancer. 1997; 71(1):108-15. DOI: 10.1002/(sici)1097-0215(19970328)71:1<108::aid-ijc18>3.0.co;2-e. View

Onken M, Ehlers J, Worley L, Makita J, Yokota Y, Harbour J . Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas. Cancer Res. 2006; 66(9):4602-9. PMC: 5407689. DOI: 10.1158/0008-5472.CAN-05-4196. View

10.

Zhang L, Huang J, Yang N, Greshock J, Megraw M, Giannakakis A . microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A. 2006; 103(24):9136-41. PMC: 1474008. DOI: 10.1073/pnas.0508889103. View

11.

Mijatovic T, Roland I, Van Quaquebeke E, Nilsson B, Mathieu A, Van Vynckt F . The alpha1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers. J Pathol. 2007; 212(2):170-9. DOI: 10.1002/path.2172. View

12.

Boukerche H, Su Z, Kang D, Fisher P . Identification and cloning of genes displaying elevated expression as a consequence of metastatic progression in human melanoma cells by rapid subtraction hybridization. Gene. 2004; 343(1):191-201. DOI: 10.1016/j.gene.2004.09.002. View

13.

Mathieu V, Mercier M, De Neve N, Sauvage S, Gras T, Roland I . Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model. J Invest Dermatol. 2007; 127(10):2399-410. DOI: 10.1038/sj.jid.5700869. View

14.

Dumont P, Ingrassia L, Rouzeau S, Ribaucour F, Thomas S, Roland I . The Amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells but not in normal fibroblasts. Neoplasia. 2007; 9(9):766-76. PMC: 1993861. DOI: 10.1593/neo.07535. View

15.

Lejeune F, Rimoldi D, Speiser D . New approaches in metastatic melanoma: biological and molecular targeted therapies. Expert Rev Anticancer Ther. 2007; 7(5):701-13. DOI: 10.1586/14737140.7.5.701. View

16.

Larriba M, Valle N, Palmer H, Ordonez-Moran P, Alvarez-Diaz S, Becker K . The inhibition of Wnt/beta-catenin signalling by 1alpha,25-dihydroxyvitamin D3 is abrogated by Snail1 in human colon cancer cells. Endocr Relat Cancer. 2007; 14(1):141-51. DOI: 10.1677/ERC-06-0028. View

17.

Grover R, Chana J, Grobbelaar A, Hudson D, Forder M, Wilson G . Measurement of c-myc oncogene expression provides an accurate prognostic marker for acral lentiginous melanoma. Br J Plast Surg. 1999; 52(2):122-6. DOI: 10.1054/bjps.1998.3024. View

18.

Hersey P, Zhuang L, Zhang X . Current strategies in overcoming resistance of cancer cells to apoptosis melanoma as a model. Int Rev Cytol. 2006; 251:131-58. DOI: 10.1016/S0074-7696(06)51004-6. View

19.

Mendell J . MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle. 2005; 4(9):1179-84. DOI: 10.4161/cc.4.9.2032. View

20.

Esquela-Kerscher A, Slack F . Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6(4):259-69. DOI: 10.1038/nrc1840. View